Internal Medicine, Hematology & Oncology · Bronx, NY
NPI
1245311414
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1695 Eastchester Road, Suite 304
Bronx, NY, 10461
Phone (718) 822-4432
Groups this clinician bills Medicare through
Medicare paid, 2024
$52K
7,679 services
Medicare patients, 2024
95
Average age 75
Drug cost, 2024
$2.6M
815 prescriptions
Company payments, 2025
$1,067
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Avi I Einzig was code 36415 (venipuncture blood collection), 236 times for 87 patients. In total Avi I Einzig billed 7,679 services in 16 codes, and Medicare paid $52K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 236 | 87 | $8.58 | $2,024 |
| 99214 Office E&M - Established | Office | 174 | 62 | $113.47 | $20K |
| 99213 Office E&M - Established | Office | 138 | 68 | $79.53 | $11K |
By year: 2022 $40K for 6,615 services; 2023 $66K for 17,164 services; 2024 $52K for 7,679 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 236 | 87 | $8.58 | $2,024 |
Medicare prescription drug claims, 2024
In 2024, the drug Avi I Einzig prescribed most often to Medicare patients was Eliquis (Apixaban), with 89 prescriptions and refills. In total Avi I Einzig wrote 815 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 89 | 123 | 18 | $67K |
| Lenalidomide Generic | 52 | 52 | Under 11 | $735K |
| Tamoxifen Citrate Generic | 40 | 96 | Under 11 | $1,190 |
| Imbruvica Ibrutinib | 39 | 39 | Under 11 | $845K |
| Imatinib Mesylate Generic | 28 | 30 | Under 11 | $81K |
| Levothyroxine Sodium Generic | 27 | 47 | Under 11 | $181 |
| Zolpidem Tartrate Generic | 27 | 27 | Under 11 | $73.2 |
| Hydroxyurea Generic | 26 | 32 | Under 11 | $439 |
| Gabapentin Generic | 26 | 35 | Under 11 | $217 |
| Prednisone Generic | 23 | 31 | Under 11 | $93.16 |
| Omeprazole Generic | 23 | 41 | Under 11 | $175 |
| Cyanocobalamin Injection Cyanocobalamin (Vitamin B-12) | 18 | 30 | Under 11 | $52.78 |
| Anagrelide Hcl Generic | 18 | 26 | Under 11 | $8,122 |
| Atorvastatin Calcium Generic | 17 | 45 | Under 11 | $101 |
| Alprazolam Generic | 16 | 17 | Under 11 | $37.56 |
Brand drugs: 201 claims; generic drugs: 614 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Avi I Einzig $1,067 ($1,067 in general payments such as food, travel and fees) from 12 companies. The largest payer was Pfizer Inc. with $252.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 15 | $252 |
| Janssen Biotech, Inc. JNJ | 10 | $208 |
| Incyte Corporation INCY | 3 | $144 |
| Abbvie Inc. ABBV | 4 | $104 |
| Genzyme Corporation SNY | 3 | $79.89 |
| GlaxoSmithKline, LLC. GSK | 3 | $74.07 |
| Gilead Sciences, Inc. GILD | 2 | $57.84 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $43.25 |
| Celgene Corporation BMY | 1 | $29.19 |
| Sumitomo Pharma America, Inc. 4506.T | 1 | $28.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.